Aarti Drugs Q2 Results

  • BSE: 524348
  • NSE: AARTIDRUGS
  • ISIN: INE767A01016
  • Sector: Biotechnology & Drugs
BSE
405.00-3.30 (-0.81%)
Volume6.71 K
Updated: Fri 5 Dec, 2025 | 15:29:02
NSE
405.00-2.85 (-0.70%)
Volume1.52 L
Updated: Fri 5 Dec, 2025 | 15:40:05
Today: 398.25
409.10
52-Wk: 312.50
574.95

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

  • Total Income
    ₹652.79 Cr.
    (9.10%)
  • Operating Profit
    ₹68.02 Cr.
    (27.57%)
  • Profit After Tax
    ₹45.28 Cr.
    (29.35%)
  • Operating Margin
    10.42%
    (16.93%)
Note: Comparison is on YoY basis

Quarterly - Aarti Drugs Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 25Jun 25QoQ CompSep 24YoY Comp
Total Operating Expense 584.77531.1510.10%545.017.30%
Depreciation/ Amortization 16.2614.7210.46%13.7218.51%
Operating Income 68.0259.3614.59%53.3227.57%
Net Income 45.2853.91-16.01%35.0129.35%
Other Operating Expenses Total 127.15112.2413.28%110.7314.83%
Net Income Before Taxes 60.4151.1118.20%45.8831.67%
Total Revenue 652.79590.5110.55%598.339.10%
Selling/ General/ Admin Expenses Total 33.0730.807.37%26.5624.51%
Diluted Normalized EPS 4.955.91-16.24%3.8329.24%

EQUITY QUICK LINKS

FROM MARKETS

RELATED LINKS

Recommended For You

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe

      Trending Now In Market

        ✕

        Wait for it…

        Log in to our website to save your bookmarks. It'll just take a moment.

        ✕

        Wait for it…

        Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.